Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

A clinically relevant liquid biopsy test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer TNBC according to new research published by a multi-institutional team of re [...]

Kisqali Combination Promising for Pre-menopausal Hormone Receptor Positive Breast Cancer

CancerConnect News The CDK46 inhibitor Kisqali ribociclib has been given breakthrough status by the US Food and Drug Administration as an initial endocrine-based treatment for of pre- or perimenopausal women with hormone-receptor positive human epidermal [...]

Five Common Sign & Symptoms of Breast Cancer

CancerConnect News Breast cancer is a cancer that originates in the area of the breast where cells replicate too quickly causing a tumor Breast cancer is most common in women but I can also occur in men Breast cancer is caused by an abnormality that is ge [...]

Acupuncture Reduces Aromatase Inhibitor Joint Pain in Women with Breast Cancer

According to a well designed study presented at the 2017 San Antonio Breast Cancer Symposium acupuncture is effective in reducing pain and stiffness associated with aromatase inhibitor AI therapy in women with early-stage breast cancer1 Stiffness and join [...]

Kisqali® Improves Outcomes of Premenopausal Women with HR+/HER2- Advanced Breast Cancer

It was announced today that results from the Phase III MONALEESA-7 trial evaluating Kisqali ribociclib in combination endocrine-based therapy in premenopausal or perimenopausal women with hormone-receptor positive human epidermal growth factor receptor-2 [...]